Why benzodiazepines are not going away-Reference-Cited by-同舟云学术

Why benzodiazepines are not going away

Published:2012-07 Issue:4 Volume:18 Page:259-262
ISSN:1355-5146
Container-title:Advances in Psychiatric Treatment
language:en
Short-container-title:Adv. psychiatr. treat

Author:

Tyrer Peter

Abstract

SummaryBenzodiazepines are still widely prescribed in psychiatry, mainly for the treatment of anxiety-related disorders. This is not because they are only taken by a hard core component of patients who are addicted and do not need them; it is because they remain the most effective and rapid acting of all drug treatments. Strategies for practitioners to use them more confidently are described.

Publisher

Cambridge University Press (CUP)

Subject

Psychiatry and Mental health

Reference22 articles.

1. International Study of Expert Judgment on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: IV. Therapeutic Dose Dependence and Abuse Liability of Benzodiazepines in the Long-Term Treatment of Anxiety Disorders

2. Benzodiazepines revisited-will we ever learn?

3. THE NOTTINGHAM STUDY OF NEUROTIC DISORDER: COMPARISON OF DRUG AND PSYCHOLOGICAL TREATMENTS

4. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-evaluating benzodiazepines for anxiety disorders – déjà-vu all over again?;BJPsych Advances;2023-01-09

2. Interventions for self-harm in children and adolescents;Cochrane Database of Systematic Reviews;2021-03-07

3. Pharmacological interventions for self-harm in adults;Cochrane Database of Systematic Reviews;2021-01-10

4. Pharmacological interventions for self-harm in adults;Cochrane Database of Systematic Reviews;2020-07-02

5. Interventions for self-harm in children and adolescents;Cochrane Database of Systematic Reviews;2020-07-02